- Home
- CTRM vs ADGM Comparison
CTRM vs ADGM Comparison
Compare CTRM & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- ADGM
- Stock Information
- Founded
- CTRM 2016
- ADGM 2011
- Country
- CTRM Cyprus
- ADGM United States
- Employees
- CTRM N/A
- ADGM N/A
- Industry
- CTRM Marine Transportation
- ADGM
- Sector
- CTRM Consumer Discretionary
- ADGM
- Exchange
- CTRM Nasdaq
- ADGM NYSE
- Market Cap
- CTRM 20.7M
- ADGM 19.7M
- IPO Year
- CTRM N/A
- ADGM N/A
- Fundamental
- Price
- CTRM $2.32
- ADGM $1.12
- Analyst Decision
- CTRM
- ADGM
- Analyst Count
- CTRM 0
- ADGM 0
- Target Price
- CTRM N/A
- ADGM N/A
- AVG Volume (30 Days)
- CTRM 62.6K
- ADGM 66.3K
- Earning Date
- CTRM 06-17-2025
- ADGM 05-15-2025
- Dividend Yield
- CTRM N/A
- ADGM N/A
- EPS Growth
- CTRM N/A
- ADGM N/A
- EPS
- CTRM 0.38
- ADGM N/A
- Revenue
- CTRM $66,243,379.00
- ADGM $576,000.00
- Revenue This Year
- CTRM N/A
- ADGM N/A
- Revenue Next Year
- CTRM N/A
- ADGM N/A
- P/E Ratio
- CTRM $6.23
- ADGM N/A
- Revenue Growth
- CTRM N/A
- ADGM 116.54
- 52 Week Low
- CTRM $1.98
- ADGM $0.63
- 52 Week High
- CTRM $5.49
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- CTRM 54.53
- ADGM N/A
- Support Level
- CTRM $2.30
- ADGM N/A
- Resistance Level
- CTRM $2.44
- ADGM N/A
- Average True Range (ATR)
- CTRM 0.11
- ADGM 0.00
- MACD
- CTRM 0.01
- ADGM 0.00
- Stochastic Oscillator
- CTRM 52.76
- ADGM 0.00
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.